TP53 p.Glu271Val
c.812A>T · rs2151016523 · VCV3147994
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9457 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.972 | strongly pathogenic-leaning |
| SaProt | LLR -13.85 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.9 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 6,982 bp · p 0.0085 · regional, not allelic |
| Overall | ||
| CADD | 27.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TP53
- Protein
- p.Glu271Val
- Coding
- c.812A>T
- MANE Select
- NM_000546
- dbSNP
- rs2151016523
- Type
- single nucleotide variant
- Location
- chr17:7673808 (GRCh38)
- Gene constraint
- LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.83 · 321 PDB
- Residue 271
- a DNA-binding region; the 'interaction with axin1' region; a UniProt-annotated variant site (in sporadic cancers; somatic mutation); a UniProt-annotated variant site (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions); a UniProt-annotated variant site (in an osteosarcoma with no family history; germline mutation and in sporadic cancers; somatic mutation); the 'interaction with e4f1' region; a β-strand; the 'interaction with ccar2' region; the 'interaction with hipk1' region; the 'required for interaction with znf385a' region
Disease context
Li-Fraumeni syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Li-Fraumeni syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (United Kingdom)
Similar variants
- TP53 p.Glu271Ter Pathogenic ★★ same residue
- TP53 p.Glu271Gln Uncertain significance ★★ ⚠ same residue
- TP53 p.Glu271= Likely benign ★★ same residue
- TP53 p.Glu271Asp Uncertain significance ★ ⚠ same residue
- TP53 p.Glu271Gly Uncertain significance ★ ⚠ same residue
- TP53 p.Glu271Lys Conflicting classifications of pathogenicity ★ ⚠ same residue
- TP53 p.Glu271del Uncertain significance ★ same residue
- TP53 p.Glu271Leu Uncertain significance ★ same residue
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-glu271val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown